MedTrace Logo

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

NCT01390480 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2015-04-17

No results posted yet for this study

Summary

In this placebo controlled study the investigators aim to investigate the effects of vitamin D supplementation in subjects with new onset of type 1 diabetes on immunological, endocrine and metabolic parameters.

Conditions

Interventions

DRUG

Cholecalciferol

weekly dose (based on 70 IU/kg bodyweight/day) orally

Sponsors & Collaborators

  • Medical University of Vienna

    collaborator OTHER

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Thomas Pieber, Prof. · Medical University of Graz

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2013-11-30
Completion
2014-02-28

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01390480 on ClinicalTrials.gov